BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs3825942
,
PBX1
,
Metabolism of xenobiotics
,
Obesity
,
Embryo
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
methylcholanthrene
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Neonatal ovarian response to 3-methylcholanthrene (3MC)
C3H/10T1/2 fibroblasts treated with 3-methylcholanthrene and 12-O-tetradecanoylphorbol-13-acetate
MEF 3T3 cells treated with four chemical carcinogens
Hepatocyte cells of Wistar rats treated with 29 different hepatotoxic compounds
Livers of rats exposed to 27 agents with different mechanisms of action for toxicity
Explore Curated Studies Results
Literature
Most Relevant Literature
Estimation of trace elements in mace (Myristica fragrans Houtt) and their effect on uterine cervix c…
Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung …
The role of cytochrome P450-dependent metabolism in the regulation of mouse hepatic growth hormone s…
Chemopreventive property of Trichosanthes dioica root against 3-methylcholanthrene-induced carcinoge…
Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ